Evidence map›Paper›PMID 41928005›Full record

ArticleThe EMBO journal2026

A leader-repeat hairpin blocks extraneous CRISPR RNA production in diverse CRISPR-Cas13 systems.

Angela Migur, Maximilian Feussner, Chunyu Liao, Omer S Alkhnbashi, Adrien Chauvier, Nils G Walter, Rolf Backofen, Zasha Weinberg, Chase L Beisel

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela MigurHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Centre for Infection Research (HZI), Würzburg, Germany.ORCID http://orcid.org/0000-0002-2065-6088
Maximilian FeussnerBioinformatics Group, Department of Computer Science and Interdisciplinary Centre for Bioinformatics, University of Leipzig, Leipzig, Germany.ORCID http://orcid.org/0009-0000-2803-0496
Chunyu LiaoFaculty of Life and Health Sciences, Shenzhen University of Advanced Technology, Shenzhen, China.
Omer S AlkhnbashiCenter for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Healthcare City, Dubai, United Arab Emirates.
Adrien ChauvierSingle Molecule Analysis Group and Center for RNA Biomedicine, Department of Chemistry, University of Michigan, Ann Arbor, USA.ORCID http://orcid.org/0000-0003-4473-6194
Nils G WalterSingle Molecule Analysis Group and Center for RNA Biomedicine, Department of Chemistry, University of Michigan, Ann Arbor, USA.ORCID http://orcid.org/0000-0002-7301-1275
Rolf BackofenUniversität Freiburg, Freiburg, Germany; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-8231-3323
Zasha WeinbergBioinformatics Group, Department of Computer Science and Interdisciplinary Centre for Bioinformatics, University of Leipzig, Leipzig, Germany.
Chase L BeiselHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Centre for Infection Research (HZI), Würzburg, Germany. chase.beisel@immune.engineering.ORCID http://orcid.org/0000-0003-0650-9943

Funding

Deutsche Forschungsgemeinschaft (DFG) 468749960Deutsche Forschungsgemeinschaft (DFG) BA 2168/23-2EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) 865973National Science Foundation (NSF) MCB 2140320
6 · The paper itself

Abstract

CRISPR RNAs (crRNAs) guide recognition and targeting of intracellular invaders as part of adaptive immunity by CRISPR-Cas systems. crRNAs are transcribed from CRISPR arrays of conserved repeats interlaced with invader-derived spacers. While crRNA production is essential for immunity, its optimization for defense remains poorly understood. Here, we show that, in diverse RNA-targeting type VI CRISPR-Cas systems, the leader RNA encoded upstream of the CRISPR array prevents formation of an invader-independent extraneous crRNA (ecrRNA) by blocking processing of the first repeat. Using the VI-B2 system from Porphyromonas gingivalis as a model, we demonstrate that the leader RNA and first repeat form a conserved inhibitory hairpin that precludes binding and processing by the system's Cas13b nuclease. Disrupting this hairpin enables ecrRNA production, which in turn can deplete invader-derived crRNAs and reduce Cas13b-mediated phage defense. Structure prediction indicates that these leader-repeat hairpins are widespread across diverse type VI subtypes, highlighting a conserved regulatory mechanism. Our findings reveal how a prevalent branch of CRISPR-Cas systems suppresses ecrRNA formation to promote RNA-guided immunity.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsPorphyromonas gingivalisRNA, BacterialBase SequenceCRISPR-Associated ProteinsNucleic Acid ConformationCRISPR-Associated ProteinsRNA, BacterialCas13bCRISPR-CasCRISPR RNAecrRNARNA ProcessingRNA Structure

Identifiers

PMID41928005
PMCPMC13187072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.